FDA Approves More Convenient Form of Roche Blood Cancer Drug FDA Approves More Convenient Form of Roche Blood Cancer Drug

U.S. health regulators on Thursday approved a new formulation of Roche's big-selling cancer drug Rituxan (rituximab) for three common types of blood cancers that allows for relatively quick administration via injection under the skin in place of a lengthy intravenous infusion, the company said.FDA Approvals (Source: Medscape Medical News Headlines)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tDSRcX
via IFTTT